Assessment of α-amanitin toxicity and effects of silibinin and penicillin in different in vitro models.

[1]  S. Forbes,et al.  Blended electrospinning with human liver extracellular matrix for engineering new hepatic microenvironments , 2019, Scientific Reports.

[2]  H. Goudarzi,et al.  Silibinin upregulates E-cadherin expression in MKN-45 human gastric cancer cells , 2018 .

[3]  S. Ohta,et al.  Comparison of Drug Metabolism and Its Related Hepatotoxic Effects in HepaRG, Cryopreserved Human Hepatocytes, and HepG2 Cell Cultures. , 2018, Biological & pharmaceutical bulletin.

[4]  J. Diaz.  Amatoxin-Containing Mushroom Poisonings: Species, Toxidromes, Treatments, and Outcomes. , 2018, Wilderness & environmental medicine.

[5]  U. Udomsubpayakul,et al.  Clinical characteristics and outcome of toxicity from Amanita mushroom poisoning , 2017, International journal of general medicine.

[6]  G. Mailhot,et al.  Phosphate-Linked Silibinin Dimers (PLSd): New Promising Modified Metabolites , 2017, Molecules.

[7]  Simon Messner,et al.  Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury , 2017, Archives of Toxicology.

[8]  Christine Unger,et al.  Comparison of cancer cells in 2D vs 3D culture reveals differences in AKT–mTOR–S6K signaling and drug responses , 2017, Journal of Cell Science.

[9]  H. Faulstich,et al.  Cyclopeptide-Containing Mushrooms: The Deadly Amanitas , 2017 .

[10]  Kristi S Anseth,et al.  Microarray analyses to quantify advantages of 2D and 3D hydrogel culture systems in maintaining the native valvular interstitial cell phenotype. , 2016, Biomaterials.

[11]  E. Kaya,et al.  A Case Study: What Doses of Amanita phalloides and Amatoxins Are Lethal to Humans? , 2015, Wilderness & environmental medicine.

[12]  Aleksandra Galetin,et al.  Meta-Analysis of Expression of Hepatic Organic Anion–Transporting Polypeptide (OATP) Transporters in Cellular Systems Relative to Human Liver Tissue , 2015, Drug Metabolism and Disposition.

[13]  T. Mukohara,et al.  Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer. , 2015, Oncology reports.

[14]  K. Maeda.  Organic anion transporting polypeptide (OATP)1B1 and OATP1B3 as important regulators of the pharmacokinetics of substrate drugs. , 2015, Biological & pharmaceutical bulletin.

[15]  T. Gudermann,et al.  Functional expression of the transient receptor potential channel TRPA1, a sensor for toxic lung inhalants, in pulmonary epithelial cells. , 2013, Chemico-biological interactions.

[16]  A. Schmidt,et al.  Silibinin as a potential therapeutic for sulfur mustard injuries. , 2013, Chemico-biological interactions.

[17]  A. Erden,et al.  Acute liver failure caused by mushroom poisoning: a case report and review of the literature , 2013, International medical case reports journal.

[18]  A. Segura‐Carretero,et al.  Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo , 2013, Scientific Reports.

[19]  Katrin Wlcek,et al.  Hepatocellular Organic Anion–Transporting Polypeptides (OATPs) and Multidrug Resistance–Associated Protein 2 (MRP2) Are Inhibited by Silibinin , 2013, Drug Metabolism and Disposition.

[20]  Elmar Heinzle,et al.  3D organotypic cultures of human HepaRG cells: a tool for in vitro toxicity studies. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[21]  R. Agarwal,et al.  Anti-Cancer Efficacy of Silybin Derivatives - A Structure-Activity Relationship , 2013, PloS one.

[22]  E. Hackett,et al.  Milk thistle and its derivative compounds: a review of opportunities for treatment of liver disease. , 2013, Journal of veterinary internal medicine.

[23]  R. Agarwal,et al.  Silibinin Attenuates Sulfur Mustard Analog-Induced Skin Injury by Targeting Multiple Pathways Connecting Oxidative Stress and Inflammation , 2012, PloS one.

[24]  Ralf-Torsten Pohl,et al.  Legalon® SIL: The Antidote of Choice in Patients with Acute Hepatotoxicity from Amatoxin Poisoning , 2012, Current pharmaceutical biotechnology.

[25]  S. Fey,et al.  Determination of Drug Toxicity Using 3D Spheroids Constructed From an Immortal Human Hepatocyte Cell Line , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[26]  R. Agarwal,et al.  Role of E-cadherin in Antimigratory and Antiinvasive Efficacy of Silibinin in Prostate Cancer Cells , 2011, Cancer Prevention Research.

[27]  J. Tavis,et al.  Differential In Vitro Effects of Intravenous versus Oral Formulations of Silibinin on the HCV Life Cycle and Inflammation , 2011, PloS one.

[28]  T. Sozański,et al.  Influence of commonly used clinical antidotes on antioxidant systems in human hepatocyte culture intoxicated with α-amanitin , 2011, Human & experimental toxicology.

[29]  P. K. Mediratta,et al.  Substitute of Animals in Drug Research: An Approach Towards Fulfillment of 4R's , 2011, Indian journal of pharmaceutical sciences.

[30]  I. Madubunyi.  Influence of silibinin on the permeability of primary cultured cell membranes , 2012, Comparative Clinical Pathology.

[31]  J. Walton,et al.  Colocalization of Amanitin and a Candidate Toxin-Processing Prolyl Oligopeptidase in Amanita Basidiocarps , 2010, Eukaryotic Cell.

[32]  Steven N. Hart,et al.  A Comparison of Whole Genome Gene Expression Profiles of HepaRG Cells and HepG2 Cells to Primary Human Hepatocytes and Human Liver Tissues , 2010, Drug Metabolism and Disposition.

[33]  Ş. Eren,et al.  Mushroom poisoning: retrospective analysis of 294 cases , 2010, Clinics.

[34]  S. Nyberg,et al.  E-Cadherin Protects Primary Hepatocyte Spheroids from Cell Death by a Caspase-Independent Mechanism , 2009, Cell transplantation.

[35]  M. Niemi,et al.  Impact of OATP transporters on pharmacokinetics , 2009, British journal of pharmacology.

[36]  D. Keppler,et al.  Molecular characterization and inhibition of amanitin uptake into human hepatocytes. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[37]  F. Panaro,et al.  Liver transplantation represents the optimal treatment for fulminant hepatic failure from amanita phalloides poisoning , 2006, Transplant international : official journal of the European Society for Organ Transplantation.

[38]  M. Roma,et al.  Silymarin as a new hepatoprotective agent in experimental cholestasis: new possibilities for an ancient medication. , 2006, Current medicinal chemistry.

[39]  L. Griffith,et al.  Capturing complex 3D tissue physiology in vitro , 2006, Nature Reviews Molecular Cell Biology.

[40]  Frank Stahl,et al.  Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[41]  S. Rapior,et al.  Treatment of Amatoxin Poisoning: 20-Year Retrospective Analysis , 2002, Journal of toxicology. Clinical toxicology.